These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32591801)

  • 1. Discovery and characterization of New Delhi metallo-β-lactamase-1 inhibitor peptides that potentiate meropenem-dependent killing of carbapenemase-producing Enterobacteriaceae.
    Kazi MI; Perry BW; Card DC; Schargel RD; Ali HB; Obuekwe VC; Sapkota M; Kang KN; Pellegrino MW; Greenberg DE; Castoe TA; Boll JM
    J Antimicrob Chemother; 2020 Oct; 75(10):2843-2851. PubMed ID: 32591801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.
    Everett M; Sprynski N; Coelho A; Castandet J; Bayet M; Bougnon J; Lozano C; Davies DT; Leiris S; Zalacain M; Morrissey I; Magnet S; Holden K; Warn P; De Luca F; Docquier JD; Lemonnier M
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
    Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the Offensive: the Role of Outer Membrane Vesicles in the Successful Dissemination of New Delhi Metallo-β-lactamase (NDM-1).
    Martínez MMB; Bonomo RA; Vila AJ; Maffía PC; González LJ
    mBio; 2021 Oct; 12(5):e0183621. PubMed ID: 34579567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
    Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J
    Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant
    Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T
    ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
    Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
    Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales.
    Ooi N; Lee VE; Chalam-Judge N; Newman R; Wilkinson AJ; Cooper IR; Orr D; Lee S; Savage VJ
    J Antimicrob Chemother; 2021 Jan; 76(2):460-466. PubMed ID: 33152764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens
    Samuelsen Ø; Åstrand OAH; Fröhlich C; Heikal A; Skagseth S; Carlsen TJO; Leiros HS; Bayer A; Schnaars C; Kildahl-Andersen G; Lauksund S; Finke S; Huber S; Gjøen T; Andresen AMS; Økstad OA; Rongved P
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANT2681: SAR Studies Leading to the Identification of a Metallo-β-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing
    Davies DT; Leiris S; Sprynski N; Castandet J; Lozano C; Bousquet J; Zalacain M; Vasa S; Dasari PK; Pattipati R; Vempala N; Gujjewar S; Godi S; Jallala R; Sathyap RR; Darshanoju NA; Ravu VR; Juventhala RR; Pottabathini N; Sharma S; Pothukanuri S; Holden K; Warn P; Marcoccia F; Benvenuti M; Pozzi C; Mangani S; Docquier JD; Lemonnier M; Everett M
    ACS Infect Dis; 2020 Sep; 6(9):2419-2430. PubMed ID: 32786279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants.
    Djoko KY; Achard MES; Phan MD; Lo AW; Miraula M; Prombhul S; Hancock SJ; Peters KM; Sidjabat HE; Harris PN; Mitić N; Walsh TR; Anderson GJ; Shafer WM; Paterson DL; Schenk G; McEwan AG; Schembri MA
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model.
    Leiris S; Coelho A; Castandet J; Bayet M; Lozano C; Bougnon J; Bousquet J; Everett M; Lemonnier M; Sprynski N; Zalacain M; Pallin TD; Cramp MC; Jennings N; Raphy G; Jones MW; Pattipati R; Shankar B; Sivasubrahmanyam R; Soodhagani AK; Juventhala RR; Pottabathini N; Pothukanuri S; Benvenuti M; Pozzi C; Mangani S; De Luca F; Cerboni G; Docquier JD; Davies DT
    ACS Infect Dis; 2019 Jan; 5(1):131-140. PubMed ID: 30427656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril potentiated meropenem activity against MBL-producing carbapenem-resistant Klebsiella pneumoniae: in vitro and in vivo study.
    Zhao D; Li H; Yue C; Sun K; Dai Y; Zhang H; Liu Y; Gao Y; Li J
    J Inorg Biochem; 2021 May; 218():111381. PubMed ID: 33647540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from China.
    Wang X; Zhao C; Wang Q; Wang Z; Liang X; Zhang F; Zhang Y; Meng H; Chen H; Li S; Zhou C; Li H; Wang H
    J Antimicrob Chemother; 2020 Jul; 75(7):1850-1858. PubMed ID: 32154866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing
    Das S; Johnson A; McEntee L; Farrington N; Kirby A; Unsworth J; Jimenez-Valverde A; Kolamunnage-Dona R; Bousquet J; Alibaud L; Sable C; Zalacain M; Everett M; Hope W
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32778549
    [No Abstract]   [Full Text] [Related]  

  • 17. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
    Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
    J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further Modification of the Modified Hodge Test for Detecting Metallo-β-Lactamase-Producing Carbapenem-Resistant Enterobacteriaceae.
    Kim HK; Park JS; Sung H; Kim MN
    Ann Lab Med; 2015 May; 35(3):298-305. PubMed ID: 25932437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific NDM-1 Inhibitor of Isoliquiritin Enhances the Activity of Meropenem against NDM-1-positive
    Wang Y; Sun X; Kong F; Xia L; Deng X; Wang D; Wang J
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32213926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive
    Zalacain M; Lozano C; Llanos A; Sprynski N; Valmont T; De Piano C; Davies D; Leiris S; Sable C; Ledoux A; Morrissey I; Lemonnier M; Everett M
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33820763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.